Xinglei Shen
Expertise in
15
conditions

Dr. Xinglei Shen

Radiation Oncology
4001 Rainbow Boulevard, 
Kansas City, KS 
On Staff At
Accepting New Patients
Offers Telehealth
19 Years of Experience
Expertise in
15
conditions
4001 Rainbow Boulevard, 
Kansas City, KS 

Overview

Xinglei Shen is a Radiation Oncologist in Kansas City, Kansas. Dr. Shen has been practicing medicine for over 19 years is highly rated in 15 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), Prostatectomy, and Orchiectomy. Dr. Shen is currently accepting new patients.

His clinical research consists of co-authoring 58 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

University Of Pittsburgh School Of Medicine, Doctor Of Medicine, 2007

Residency

Thomas Jefferson University Hospitals, Radiation Oncology, 2012

Specialties

Radiation Oncology

Licenses

Radiology in KS

Board Certifications

American Board Of Radiology, Radiation Oncology - 2013

Hospital Affiliations

University Of Kansas Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Richard and Annette Bloch Radiation Oncology Pavilion
4001 Rainbow Boulevard, Kansas City, KS 66160

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer
A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Radiation
Study Phase: Not Applicable
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
Enrollment Status: Active_not_recruiting
Publish Date: January 30, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Completed
Publish Date: January 14, 2026
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
Enrollment Status: Active_not_recruiting
Publish Date: January 14, 2026
Intervention Type: Other, Radiation, Drug
Study Drug: Apalutamide
Study Phase: Phase 2
STEEL: A Randomized Phase II Trial of Salvage Radiotherapy With Standard vs Enhanced Androgen Deprivation Therapy (With Enzalutamide) in Patients With Post-Prostatectomy PSA Recurrences With Aggressive Disease Features
STEEL: A Randomized Phase II Trial of Salvage Radiotherapy With Standard vs Enhanced Androgen Deprivation Therapy (With Enzalutamide) in Patients With Post-Prostatectomy PSA Recurrences With Aggressive Disease Features
Enrollment Status: Active_not_recruiting
Publish Date: December 30, 2025
Intervention Type: Radiation, Drug
Study Drugs: Enzalutamide, Bicalutamide, GnRH analog
Study Phase: Phase 2
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: October 28, 2025
Intervention Type: Radiation
Study Phase: Phase 3
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2025
Intervention Type: Biological, Drug, Radiation
Study Drugs: Gonadotrophin releasing hormone, Niraparib
Study Phase: Phase 1/Phase 2
View 8 Less Clinical Trials

58 Total Publications

An Oversampling-Enhanced Multi-Class Imbalanced Classification Framework for Patient Health Status Prediction Using Patient-Reported Outcomes.
An Oversampling-Enhanced Multi-Class Imbalanced Classification Framework for Patient Health Status Prediction Using Patient-Reported Outcomes.
Journal: IEEE access : practical innovations, open solutions
Published: October 23, 2025
Similar Doctors
Fen Wang
Expertise in
44
conditions
Dr. Fen Wang
Radiation Oncology
Expertise in
44
conditions
Dr. Fen Wang
Radiation Oncology

Richard And Annette Bloch Radiation Oncology Pavilion

4001 Rainbow Boulevard, 
Kansas City, KS 
 (3.9 miles away)
913-588-1227
Experience:
42+ years
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients
Offers Telehealth

Fen Wang is a Radiation Oncologist in Kansas City, Kansas. Dr. Wang has been practicing medicine for over 42 years is highly rated in 44 conditions, according to our data. His top areas of expertise are Meningioma, Lung Cancer, Pleuropulmonary Blastoma, and Posterior Fossa Tumor. Dr. Wang is currently accepting new patients.

Ronny L. Rotondo
Expertise in
35
conditions
Dr. Ronny L. Rotondo
Radiation Oncology
Expertise in
35
conditions
Dr. Ronny L. Rotondo
Radiation Oncology

Richard And Annette Bloch Radiation Oncology Pavilion

4001 Rainbow Boulevard, 
Kansas City, KS 
 (3.9 miles away)
913-588-1227
Experience:
21+ years
Languages Spoken:
English, French, Italian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Ronny Rotondo is a Radiation Oncologist in Kansas City, Kansas. Dr. Rotondo has been practicing medicine for over 21 years is highly rated in 35 conditions, according to our data. His top areas of expertise are Chordoma, Adult Soft Tissue Sarcoma, Bone Tumor, and Ewing Sarcoma. Dr. Rotondo is currently accepting new patients.

Andrew C. Hoover
Expertise in
12
conditions
Dr. Andrew C. Hoover
Radiation Oncology
Expertise in
12
conditions
Dr. Andrew C. Hoover
Radiation Oncology

Richard And Annette Bloch Radiation Oncology Pavilion

4001 Rainbow Boulevard, 
Kansas City, KS 
 (3.9 miles away)
913-588-1227
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Hoover is a Radiation Oncologist in Kansas City, Kansas. Dr. Hoover has been practicing medicine for over 16 years is highly rated in 12 conditions, according to our data. His top areas of expertise are Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Endometrial Cancer, and Endometrial Stromal Sarcoma. Dr. Hoover is currently accepting new patients.

Frequently Asked Questions about Dr. Xinglei Shen

How do I make an appointment with Dr. Xinglei Shen?

You can book an appointment with Dr. Xinglei Shen by calling their office at 913-588-1227. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Xinglei Shen a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Xinglei Shen is classified as an Elite expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Xinglei Shen specialize in?

While Dr. Xinglei Shen is a Radiation Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Upper Tract Urothelial Carcinoma (UTUC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Xinglei Shen participate in research or clinical trials?

Yes. Dr. Xinglei Shen has published 58 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Xinglei Shen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Xinglei Shen accept my insurance?

Dr. Xinglei Shen accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 913-588-1227 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shen's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 50 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile